Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Although genetic polymorphisms in NOD2 (nucleotide-binding oligomerization domain-containing 2) have been associated with the pathogenesis of Crohn's disease (CD), little is known regarding the role of wild-type (WT) NOD2 in the gut. To date, most murine studies addressing the role of WT Nod2 have been conducted using healthy (ileitis/colitis-free) mouse strains. Here, we evaluated the effects of Nod2 deletion in a murine model of spontaneous ileitis, i.e., the SAMP1Yit/Fc (SAMP) strain, which closely resembles CD. Remarkably, Nod2 deletion improved both chronic cobblestone ileitis (by 50% assessed, as the % of abnormal mucosa at 24 wks of age), as well as acute dextran sodium sulfate (DSS) colitis. Mechanistically, Th2 cytokine production and Th2-transcription factor activation (i.e., STAT6 phosphorylation) were reduced. Microbiologically, the effects of Nod2 deletion appeared independent of fecal microbiota composition and function, assessed by 16S rRNA and metatranscriptomics. Our findings indicate that pharmacological blockade of NOD2 signaling in humans could improve health in Th2-driven chronic intestinal inflammation.

Original publication

DOI

10.1038/mi.2016.98

Type

Journal article

Journal

Mucosal Immunol

Publication Date

07/2017

Volume

10

Pages

971 - 982

Keywords

Animals, Colitis, Crohn Disease, Cytokines, Dextran Sulfate, Disease Models, Animal, Disease Susceptibility, Dysbiosis, Feces, Humans, Ileitis, Intestinal Mucosa, Mice, Mice, Knockout, Mice, Mutant Strains, Microbiota, Nod2 Signaling Adaptor Protein, RNA, Ribosomal, 16S, Receptors, Pattern Recognition, STAT6 Transcription Factor